Since MMP2 and MMP9 belong to the same subtype of matrix metalloproteinases and share similar mechanism in promoting carcinogenesis, it is necessary to explore the prognostic value of the co-expression of both proteins in BC patients. The gene discussed is MMP2; the disease is breast cancer.